Month: May 2021

Company announcement – No. 28/ 2021 Zealand Pharma launches long-term incentive program for Zealand’s Executive Management and employees for 2021 Copenhagen, DK and Boston, MA, U.S. May 5, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announces the implementation of a new share-based long-term incentive program for Zealand’s employees based in Denmark and the US as well as certain members of the Executive Management employed in Denmark, in accordance with Zealand’s Remuneration Policy as adopted at the annual general meeting held on 15 April 2021. Zealand implemented the new incentive program to align with selected biotech peers, and is intended to drive long-term performance, align management’s...

The composting area at CNH Industrial’s plant in Sorocaba, BrazilThe composting area at CNH Industrial’s plant in Sorocaba, BrazilLondon, May 12, 2021 Fabio Belasco, Health and Safety specialist for CNH Industrial in Brazil, is a man on a mission. The goal? To achieve zero-waste at all of the Company’s manufacturing plants right across the country. An ambitious target but one that is already within reach. Follow CNH Industrial’s path to zero-waste across South America at: https://www.cnhindustrial.com/ThePathToZeroWaste For CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) the creation of a circular approach in its manufacturing processes is one aspect of the Company’s sustainability priority “Life Cycle Thinking”. This latest Top Stories installment focuses on how this vision is becoming a reality at CNH Industrial’s...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — Ascendant Resources (TSX: ASND) (“Ascendant” or the “Company”) is pleased to announce that it plans to host an investor call on Thursday May 13 at 12:00 pm to provide updated guidance on the development plan for Lagoa Salgada. Ascendant would also like to formally introduce Joao Barros, Ascendant’s newly appointed President. Meeting Details Below:Topic: Ascendant Investor Update Time: May 13, 2021 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://zoom.us/j/96168110188?pwd=dS9HY3l3VVY1Sm96UFhFaUVYUnZ4dz09 Meeting ID: 961 6811 0188 Passcode: 158299 One tap mobile +13126266799,,96168110188#,,,,*158299# US (Chicago) +13462487799,,96168110188#,,,,*158299# US (Houston) Dial by your location +1...

— First Patient to Be Enrolled this Week in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High Risk Hospitalized COVID-19 Patients– –New Drug Application Accepted for Review by FDA for Proprietary TADFIN Daily Oral Dosing Combination for BPH; PDUFA Date December 2021– –Company Poised to Enroll First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin for Metastatic Castration and AR Targeting Agent Resistant Prostate Cancer Later this Month– –Company Anticipates Enrolling First Patient in Phase 2 Clinical Trial of VERU-100 Novel Long-Acting GnRH Antagonist Depot as Androgen Deprivation Therapy for Advanced Prostate Cancer Later this Month– –Company to Host Investor Conference Call Today at 8 a.m. ET– MIAMI, May 12, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ:...

CALGARY, Alberta, May 12, 2021 (GLOBE NEWSWIRE) — Eguana Technologies (TSX.V: EGT) (OTCQB: EGTYF) is pleased to announce its 10kW Evolve product has completed construction review and is proceeding to final system certification ahead of schedule. This critical milestone allows the Company to begin procuring materials for first production units planned in July and customer shipments through the summer. The 10kw Evolve provides homeowners with an integrated, heavy-duty, home battery, with twice the power and storage capacity of leading competitors, giving homeowners longer duration back up power modes. In addition, it will perform an important role in virtual power plant (“VPP”) infrastructure builds given its increased power and expandable storage capacity. “Customer preferences in the US continue to rapidly shift towards larger...

Dr. Rudolph TanziDr. Rudolph TanziTORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company’s scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital. “Dr. Rudy Tanzi has been a valuable member of our scientific advisory board for years,...

SUNNYVALE, Calif., May 12, 2021 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of omnichannel customer engagement solutions, today announced that management is scheduled to present at the 16th Annual Needham Virtual Technology & Media Conference on Monday, May 17, 2021 at 3:45 pm ET, with virtual one-on-one meetings with investors held throughout the day. To access a live audio webcast or replay of eGain’s presentation, please click on the following link https://wsw.com/webcast/needham108/egan/2217225 or visit the investor relations section of eGain’s website at http://www.egain.com/company/investors. For additional information or to schedule a meeting with eGain management, please contact either your Needham representative, or MKR Investor Relations, eGain’s investor relations firm, at egan@mkr-group.com. About...

WILLIAMSBURG, Va., May 12, 2021 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a “REIT”), today reported its consolidated results for the first quarter ended March 31, 2021. The Company’s results include the following*:  Three Months Ended    March 31, 2021     March 31, 2020               ($ in thousands except per share data)  Total Revenue $ 22,636     $ 37,208  Net loss attributable to common stockholders   (9,065 )     (14,324 )               EBITDA   3,290       1,606  Hotel EBITDA   4,201       5,059                 FFO attributable to common stockholders and unitholders   (4,800 )     (10,566 )Adjusted FFO attributable to common stockholders and unitholders   (5,173 )     (3,626 )               Net...

Efecte Plc - Managers' transactions - Schumacher ____________________________________________   Person subject to the notification requirement Name: Schumacher, Steffan Position: Other senior manager Issuer: Efecte Plc LEI: 7437005U8P0KDN6RKW34   Notification type: INITIAL NOTIFICATION Reference number: 7437005U8P0KDN6RKW34_20210511104412_41 ____________________________________________   Transaction date: 2021-05-10 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Efecte Oyj 2018A-option Nature of the transaction: DISPOSAL (X) Linked to stock option programme   Transaction details (1): Volume: 28000 Unit price: 8.95 EUR   Aggregated transactions (1): Volume: 28000 Volume weighted average price: 8.95 EUR   Further inquiries: Taru MäkinenCFOEfecte Plctaru.makinen@efecte.com+358...